featured
ENZA-p: Enzalutamide and 177Lu–PSMA-617 in Patients With Poor-Risk mCRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: